News Release

Hyaluronate reverses skin atrophy

Peer-Reviewed Publication

PLOS

The gradual loss of epidermis and dermis—skin atrophy—is clinically important because aging skin is more fragile and heals slower than young skin and is also prone to ulceration. No-one knows why skin atrophy occurs, but it is becoming more common as people live longer, and there is no effective treatment for it. One characteristic of atrophic skin is that, compared to normal skin, it contains less hyaluronate—a large carbohydrate component of the extracellular matrix, the material that surrounds cells. Results of a new study in PLoS Medicine provide the first indications that application of hyaluronate to atrophic skin might be useful therapeutically and suggest that clinical investigation is warranted.

###

* * * * * * * * EMBARGO: MONDAY, 18 December, 5 P.M. PST * * * * * * *

PLEASE MENTION THE OPEN-ACCESS JOURNAL PLoS MEDICINE (www.plosmedicine.org) AS THE SOURCE FOR THESE ARTICLES AND PROVIDE A LINK TO THE FREELY-AVAILABLE TEXT. THANK YOU.

All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere—to read, download, redistribute, include in databases, and otherwise use—subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.

Citation: Kaya G, Tran CT, Sorg O, Hotz R, Grand D. et al. (2006) Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism. PLoS Med 3(12): e493.

PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/"request=get-document&doi=10.1371/journal.pmed.0030493

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-03-12-kaya.pdf

Related image for press use: http://www.plos.org/press/plme-03-12-kaya.jpg

- Caption: Restoration of skin thickness by HAFi. Atrophic skin in an elderly indivudual before (left) and after 1 month of topical application of a 1% HAFi solution (right). (Photographer: José Fraga)

CONTACTS:
Gürkan Kaya
University Hospital of Geneva
Department of Dermatology
Geneva, 1211 Switzerland
gkaya@hcuge.ch

About PLoS Medicine

PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org

About the Public Library of Science

The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.